SEC 13F Intelligence

Nj State Employees Deferred Compensation Plan / LLY

Nj State Employees Deferred Compensation Plan’s Eli Lilly & Co Position

Does Nj State Employees Deferred Compensation Plan own Eli Lilly & Co (LLY)? Not currently — the last reported position was 18.2K shares worth $14M in Q3 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$14M
Q3 2025
Shares
18.2K
% of Portfolio
+1.53%
Quarters Held
26
position exited

Position History LLY

Reported value by quarter
Q1 ’19: $3MQ1 ’19Q2 ’19: $3MQ3 ’19: $3MQ4 ’19: $4MQ2 ’20: $5MQ2 ’20Q3 ’20: $4MQ4 ’20: $5MQ1 ’21: $5MQ2 ’21: $6MQ2 ’21Q3 ’21: $6MQ4 ’21: $7MQ1 ’22: $8MQ2 ’22: $9MQ2 ’22Q3 ’22: $8MQ4 ’22: $9MQ1 ’23: $8MQ2 ’23: $11MQ2 ’23Q3 ’23: $12MQ4 ’23: $13MQ1 ’24: $16MQ2 ’24: $16MQ2 ’24Q3 ’24: $15MQ4 ’24: $13MQ1 ’25: $14MQ2 ’25: $13MQ2 ’25Q3 ’25: $14Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q3 202518.2K$14M+1.53%
Q2 202517.2K$13M+1.58%
Q1 202517.2K$14M+1.82%
Q4 202417.2K$13M+1.61%
Q3 202417.2K$15M+1.81%
Q2 202417.2K$16M+1.93%
Q1 202420.6K$16M+2.03%
Q4 202321.7K$13M+1.74%
Q3 202322.6K$12M+1.84%
Q2 202324.5K$11M+1.66%
Q1 202324.5K$8M+1.30%
Q4 202224.5K$9M+1.45%
Q3 202226.3K$8M+1.46%
Q2 202226.3K$9M+1.39%
Q1 202226.3K$8M+1.02%
Q4 202126.3K$7M+0.91%
Q3 202126.3K$6M+0.82%
Q2 202126.3K$6M+0.80%
Q1 202126.3K$5M+0.70%
Q4 202028.6K$5M+0.74%
Q3 202028.6K$4M+0.76%
Q2 202028.6K$5M+0.88%
Q4 201928.6K$4M+0.64%
Q3 201928.6K$3M+0.58%
Q2 201924.0K$3M+0.48%
Q1 201924.0K$3M+0.57%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Nj State Employees Deferred Compensation Plan’s full portfolio or all institutional holders of LLY.